282 related articles for article (PubMed ID: 31941005)
1. Systemic Actions of Breast Cancer Facilitate Functional Limitations.
Wang R; Nakshatri H
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31941005
[TBL] [Abstract][Full Text] [Related]
2. Aging-associated skeletal muscle defects in HER2/Neu transgenic mammary tumor model.
Wang R; Kumar B; Bhat-Nakshatri P; Prasad MS; Jacobsen MH; Ovalle G; Maguire C; Sandusky G; Trivedi T; Mohammad KS; Guise T; Penthala NR; Crooks PA; Liu J; Zimmers T; Nakshatri H
JCSM Rapid Commun; 2021; 4(1):24-39. PubMed ID: 33842876
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Dual Inhibition of Tumor and Tumor-Induced Functional Limitations in a Transgenic Model of Breast Cancer.
Wang R; Bhat-Nakshatri P; Padua MB; Prasad MS; Anjanappa M; Jacobson M; Finnearty C; Sefcsik V; McElyea K; Redmond R; Sandusky G; Penthala N; Crooks PA; Liu J; Zimmers T; Nakshatri H
Mol Cancer Ther; 2017 Dec; 16(12):2747-2758. PubMed ID: 28978719
[TBL] [Abstract][Full Text] [Related]
4. Molecular therapeutic strategies targeting pancreatic cancer induced cachexia.
Yakovenko A; Cameron M; Trevino JG
World J Gastrointest Surg; 2018 Dec; 10(9):95-106. PubMed ID: 30622678
[TBL] [Abstract][Full Text] [Related]
5. Combined effect of aerobic interval training and selenium nanoparticles on expression of IL-15 and IL-10/TNF-α ratio in skeletal muscle of 4T1 breast cancer mice with cachexia.
Molanouri Shamsi M; Chekachak S; Soudi S; Quinn LS; Ranjbar K; Chenari J; Yazdi MH; Mahdavi M
Cytokine; 2017 Feb; 90():100-108. PubMed ID: 27863332
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle regeneration in cancer cachexia.
Bossola M; Marzetti E; Rosa F; Pacelli F
Clin Exp Pharmacol Physiol; 2016 May; 43(5):522-7. PubMed ID: 26857538
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle function during the progression of cancer cachexia in the male Apc
VanderVeen BN; Hardee JP; Fix DK; Carson JA
J Appl Physiol (1985); 2018 Mar; 124(3):684-695. PubMed ID: 29122966
[TBL] [Abstract][Full Text] [Related]
8. Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness.
Hesse E; Schröder S; Brandt D; Pamperin J; Saito H; Taipaleenmäki H
JCI Insight; 2019 Apr; 5(9):. PubMed ID: 30965315
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory factor TNF-α promotes the growth of breast cancer via the positive feedback loop of TNFR1/NF-κB (and/or p38)/p-STAT3/HBXIP/TNFR1.
Cai X; Cao C; Li J; Chen F; Zhang S; Liu B; Zhang W; Zhang X; Ye L
Oncotarget; 2017 Aug; 8(35):58338-58352. PubMed ID: 28938560
[TBL] [Abstract][Full Text] [Related]
10. [Systemic and local mechanisms leading to cachexia in cancer].
Grabiec K; Burchert M; Milewska M; Błaszczyk M; Grzelkowska-Kowalczyk K
Postepy Hig Med Dosw (Online); 2013 Dec; 67():1397-409. PubMed ID: 24493689
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB.
Langen RC; Schols AM; Kelders MC; Wouters EF; Janssen-Heininger YM
FASEB J; 2001 May; 15(7):1169-80. PubMed ID: 11344085
[TBL] [Abstract][Full Text] [Related]
12. A Narrative Review of Cancer-Related Fatigue (CRF) and Its Possible Pathogenesis.
Yang S; Chu S; Gao Y; Ai Q; Liu Y; Li X; Chen N
Cells; 2019 Jul; 8(7):. PubMed ID: 31323874
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.
Chacon-Cabrera A; Fermoselle C; Urtreger AJ; Mateu-Jimenez M; Diament MJ; de Kier Joffé ED; Sandri M; Barreiro E
J Cell Physiol; 2014 Nov; 229(11):1660-72. PubMed ID: 24615622
[TBL] [Abstract][Full Text] [Related]
14. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
15. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
16. Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation.
VanderVeen BN; Fix DK; Carson JA
Oxid Med Cell Longev; 2017; 2017():3292087. PubMed ID: 28785374
[TBL] [Abstract][Full Text] [Related]
17. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia.
Guttridge DC; Mayo MW; Madrid LV; Wang CY; Baldwin AS
Science; 2000 Sep; 289(5488):2363-6. PubMed ID: 11009425
[TBL] [Abstract][Full Text] [Related]
18. Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response.
Guo D; Wang C; Wang Q; Qiao Z; Tang H
Oncotarget; 2017 Jun; 8(24):39640-39648. PubMed ID: 28489606
[TBL] [Abstract][Full Text] [Related]
19. Paeonia lactiflora root extract suppresses cancer cachexia by down-regulating muscular NF-κB signalling and muscle-specific E3 ubiquitin ligases in cancer-bearing mice.
Bae T; Jang J; Lee H; Song J; Chae S; Park M; Son CG; Yoon S; Yoon Y
J Ethnopharmacol; 2020 Jan; 246():112222. PubMed ID: 31505213
[TBL] [Abstract][Full Text] [Related]
20. The expression pattern of myogenic regulatory factors MyoD, Myf6 and Pax7 in postnatal porcine skeletal muscles.
Ropka-Molik K; Eckert R; Piórkowska K
Gene Expr Patterns; 2011; 11(1-2):79-83. PubMed ID: 20888930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
